Health and Human Services Secretary Robert F. Kennedy Jr. continues to lead the department over 15 months after his February 2025 swearing-in, anchoring trader consensus at 68.5% against his departure by December 31, 2026. Recent staff turnover—including chief spokesperson Rich Danker's resignation on May 13 over flavored e-cigarette policy disputes and FDA Commissioner Marty Makary's exit amid internal pressures—has fueled speculation, but RFK Jr. persists with public duties like April 2026 congressional testimonies defending the FY2026 HHS budget request amid cuts and hiring plans. April rumors of White House sidelining his team for Big Pharma influences have not materialized into his ouster, reflecting administration stability and lack of impeachment or resignation signals ahead of midterm elections.
Ringkasan eksperimental yang dihasilkan AI dengan referensi data Polymarket. Ini bukan saran trading dan tidak berperan dalam bagaimana pasar ini diselesaikan. · Diperbarui$18,792 Vol.
$18,792 Vol.
$18,792 Vol.
$18,792 Vol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Pasar Dibuka: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Health and Human Services Secretary Robert F. Kennedy Jr. continues to lead the department over 15 months after his February 2025 swearing-in, anchoring trader consensus at 68.5% against his departure by December 31, 2026. Recent staff turnover—including chief spokesperson Rich Danker's resignation on May 13 over flavored e-cigarette policy disputes and FDA Commissioner Marty Makary's exit amid internal pressures—has fueled speculation, but RFK Jr. persists with public duties like April 2026 congressional testimonies defending the FY2026 HHS budget request amid cuts and hiring plans. April rumors of White House sidelining his team for Big Pharma influences have not materialized into his ouster, reflecting administration stability and lack of impeachment or resignation signals ahead of midterm elections.
Ringkasan eksperimental yang dihasilkan AI dengan referensi data Polymarket. Ini bukan saran trading dan tidak berperan dalam bagaimana pasar ini diselesaikan. · Diperbarui
Hati-hati dengan link eksternal.
Hati-hati dengan link eksternal.
Pertanyaan yang Sering Diajukan